Strength Training Effective for Managing Blood Pressure, Study Finds

Translate to Spanish or other 102 languages!

Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes
Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes

Medical News Today

- Advertisement -
  • High blood pressure or hypertension is a common condition that can lead to serious problems without proper management. 
  • High blood pressure management can involve using medications and lifestyle modifications. 
  • Data from a systematic review and meta-analysis found that strength training may be an effective non-medication option for the management of high blood pressure. However, its effectiveness depends on factors like intensity level and duration.

Follow the link below to read the full story on Medical News Today: https://www.medicalnewstoday.com/articles/hypertension-strength-training-helps-manage-high-blood-pressure?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-04-14&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -